Radiation-associated angiosarcoma of the breast: radical resection technique of the entire radiation field

被引:0
|
作者
Thiel, Johannes Tobias [1 ]
Bauer, Michael [1 ]
Daigeler, Adrien
Kavaka, Vladyslav [1 ]
Kolbenschlag, Jonas [1 ]
Steiner, Dominik [1 ]
Storz, Anna [1 ]
Hoffmann, Sebastian [1 ]
机构
[1] Univ Tubingen, BG Trauma Ctr Tubingen, Dept Hand Plast Reconstruct & Burn Surg, Schnarrenbergstr 95, D-72076 Tubingen, Germany
关键词
breast; breast-conserving therapy; chemotherapy; radiation-associated angiosarcoma; surgical technique; MANAGEMENT; CANCER; SURVEILLANCE; SURVIVAL; OUTCOMES; THERAPY; RAAS; RARE;
D O I
10.1177/17588359251317842
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Radiation-associated angiosarcoma of the breast (RAASB) is a rare secondary angiosarcoma that typically develops subsequent to breast-conserving therapy for breast cancer. The parameters of the resection width and depth remain the subject of considerable controversy. More recent data indicate that radical resection of the complete radiation field at the thorax is associated with improved local control and survival.Objectives: The present study investigates the radical resection technique of the entire radiation field and subsequent defect coverage in RAASB, as well as the medium-term follow-up.Design: Monocentric, retrospective, and non-comparative study.Methods: From January 2017 to January 2024 a total of 10 patients with RAASB were treated at our hospital. The radical resection technique was employed in the treatment of all patients, encompassing the entire radiation field. Three patients received local flaps (two of whom received vertical and transversal rectus abdominis muscle flaps and one received a local random pattern flap), while the remaining seven were treated with split-thickness skin grafts for defect coverage.Results: The median age at initial diagnosis of breast cancer was 59.3 +/- 9.41 years, while that of RAASB was 66.2 +/- 8.32 years. The median latency period between the start of irradiation of the chest wall and the initial presentation of RAASB was 6.5 +/- 3.08 years. The cumulative median total radiation dose was 57.23 +/- 8.34 Gray (cumulative Gray) in 9 of the 10 patients. The overall survival (OS) was 80% in the cohort, with a median follow-up period of 40.0 +/- 27.96 months. Three patients exhibited local relapses following radical resection, with two of these patients ultimately succumbing to their condition.Conclusion: Patients with RAASB may benefit from a radical resection of the entire radiation field. Despite the relatively mutilating nature of the procedure, the radical resection technique may have the potential to reduce the rate of local recurrence and prolong OS.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma
    Looi, Wen Shen
    Bradley, Julie A.
    Liang, Xiaoying
    Shaw, Christiana M.
    Leyngold, Mark
    Vega, Raymond B. Mailhot
    Brooks, Eric D.
    Rutenberg, Michael S.
    Spiguel, Lisa R.
    Giap, Fantine
    Mendenhall, Nancy P.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2022, 8 (04) : 55 - 67
  • [42] Multidisciplinary Intervention in Radiation-Associated Angiosarcoma of the Breast: Patterns of Recurrence and Response to Treatment
    Guram, Sheena
    Covelli, Andrea M.
    O'Neill, Anne C.
    Shultz, David B.
    Demicco, Elizabeth G.
    Gupta, Abha A.
    Gladdy, Rebecca A.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (01) : 522 - 532
  • [43] Multidisciplinary Intervention in Radiation-Associated Angiosarcoma of the Breast: Patterns of Recurrence and Response to Treatment
    Sheena Guram
    Andrea M. Covelli
    Anne C. O’Neill
    David B. Shultz
    Elizabeth G. Demicco
    Abha A. Gupta
    Rebecca A. Gladdy
    Annals of Surgical Oncology, 2022, 29 : 522 - 532
  • [44] Cutaneous Radiation-Associated Angiosarcoma of the Breast: Poor Prognosis in a Rare Secondary Malignancy
    Elizabeth A. Morgan
    David E. Kozono
    Qian Wang
    Carlos M. Mery
    James E. Butrynski
    Elizabeth H. Baldini
    Suzanne George
    Alessandra F. Nascimento
    Chandrajit P. Raut
    Annals of Surgical Oncology, 2012, 19 : 3801 - 3808
  • [45] Comparison of β-Adrenergic Receptor Expression in De novo and Radiation-Associated Breast Angiosarcoma
    Khan, Mohammad S.
    Balzer, Bonnie
    Chung, Fai
    Dadmanesh, Farnaz
    LABORATORY INVESTIGATION, 2018, 98 : 78 - 78
  • [46] Radiation-associated Angiosarcoma Presenting as Massive Pleural Effusion
    Ogino, Hirokazu
    Tobiume, Makoto
    Kagawa, Kozo
    Kawano, Hiroshi
    Sakaguchi, Satoshi
    Saijo, Atsuro
    Matsumoto, Daisuke
    Takizawa, Hiromitsu
    Morikawa, Yuriko
    Bando, Yoshimi
    Goto, Hisatsugu
    Nokihara, Hiroshi
    Nishioka, Yasuhiko
    INTERNAL MEDICINE, 2022, 61 (09) : 1393 - 1397
  • [47] A Case of Radiation-Associated Angiosarcoma After Laryngeal Cancer
    Agnew, Andrew
    Fornelli, Rick
    Depowski, Peter
    ENT-EAR NOSE & THROAT JOURNAL, 2020, 99 (03) : 179 - 180
  • [48] Radiation-associated angiosarcoma of the breast: analysis of diagnostic tools in a registry-based population
    Salminen, Samuli Henri
    Sampo, Mika M.
    Bohling, Tom O.
    Salo, Juho
    Tarkkanen, Maija
    Blomqvist, Carl P.
    Hukkinen, Katja
    ACTA RADIOLOGICA, 2022, 63 (01) : 22 - 27
  • [49] The capillary lobule variant of radiation-associated angiosarcoma in the setting of breast cancer: A diagnostic pitfall
    Agrawal, Shruti
    Fritchie, Karen J.
    Fernandez, Anthony P.
    Ko, Jennifer S.
    Bergfeld, Wilma
    Rubin, Brian P.
    Billings, Steven D.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2023, 50 (02) : 140 - 146
  • [50] Differences in potential key genes and pathways between primary and radiation-associated angiosarcoma of the breast
    Wei, Yuanfeng
    Yang, Xi
    Gao, Limin
    Xu, Yong
    Yi, Cheng
    TRANSLATIONAL ONCOLOGY, 2022, 19